ADMA	Asymmetric dimethylarginine
Ang II	Angiotensin II
BNP	Brain natriuretic peptide
CACs	Circulating angiogenic cells
CAD	Coronary artery disease
CHF	Congestive heart failure
cGMP	3′,5′-cyclic guanosine monophosphate
CKD	Chronic kidney disease
COX-2	Cyclooxygenase-2
CPCs	Circulating progenitor cells
CVRF	Cardiovascular risk factors
DDAH	Dimethylarginine dimethylaminohydrolase
EDCF	Endothelium-derived contracting factor
EDHF	Endothelium-derived hyperpolarizing factor
EDRF	Endothelium-derived relaxing factor
eNOS	Endothelial nitric oxide synthase
EPCs	Endothelial progenitor cells
ET	Exercise training
FGFR1	Fibroblast growth factor receptor-1
FMD	Flow-mediated dilation
FSS	Flow shear stress
GM-CSF	Granulocyte-macrophage colony-stimulating factor
HF	Heart failure
HIIT	High-intensity interval training
HMG-CoA	Hydroxymethylglutaryl-coenzyme A
HMGB1	High-mobility group box 1
HRR	Heart rate reserve
H2O2	Hydrogen peroxide
IGF-1	Insulin-like growth factor-1
IPC	Intermittent pneumatic compression
IRS	Insulin receptor substrate
NO	Nitric oxide
NOS	Nitric oxide synthase
PAD	Peripheral arterial disease
PDGF	Platelet-derived growth factor
PGI2	Prostacyclin I2
RHI	Reactive hyperemia index
ROS	Reactive oxygen species
SET	Supervised exercise training
VEGF	Vascular endothelial growth factor
VEGFR2	Vascular endothelial growth factor receptor-2
VO2 peak	Peak oxygen consumption
VO2 max	Maximum oxygen consumption
VSMC	Vascular smooth muscle cell